Article Information
History
- August 18, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Mohsen Yaghoubi1,
- Mehdi Javanbakht2,*,
- Atefeh Mashayekhi2,
- Mohsen Rezaei Hemami3,
- Michael Branagan-Harris4 and
- Thomas R Keeble5
- 1Mercer University, College of Pharmacy, Atlanta, GA, U.S
- 2Optimax Access UK Ltd, Market Access Consultancy, UK
- 3Independent health economist, Glasgow, UK
- 4Device Access UK Ltd, Market Access Consultancy, UK
- 5Essex Cardiothoracic centre, Basildon, UK, Anglia Ruskin School of medicine, Chelmsford, UK
- ↵*Corresponding Author: Mehdi Javanbakht (MSc, PhD), Mailing Address: Optimax Access UK Ltd, Kenneth Dibben House, Enterprise Rd, Chilworth, Southampton Science Park, Southampton SO16 7NS, UK., Telephone Number: 0044 7546456414, E-Mail Address: Mehdi.Javanbakht{at}Optimaxaccess.com